Health Technology Assessment – Joint BBS/EFSPI Seminar Flyer PDF
Health Technology Assessment – Joint BBS/EFSPI Seminar Program PDF
Health Technology Assessment – Joint BBS/EFSPI Seminar Summary PDF
Actelion Pharmaceuticals, Hegenheimermattweg 91, 4123 Allschwil (direction PDF, building map GIF).
European Statistical Meeting Health Technology Assessment
Fred Sorenson, Health Technology Assessment – Why is it so important?
Matthias Egger and Mike Chambers, Moving HTA forward: The challenges of incorporating real world evidence into Health Technology Assessment
Mike Chambers and Matthias Egger, GetReal: Clinical effectiveness in drug development
Claudia Nicolay, Health Technology Assessment – What’s in for Stats?
Jens Grüger, HTA and personalized healthcare
Skip Olson, HTA – Use of observational, retrospective or prospective studies
Bruno Falissard, The place of subjectivity in the French system (HAS): a good thing or an archaism?
Ralf Bender, Biometrical topics of Health Technology Assessment in Germany
Friedhelm Leverkus, 30 Months AMNOG Health Technology Assessment: Outcomes and Issues
Lou Garrison, HTA in Emerging Markets: A Framework and Examples
Richard Nixon, Using early health economic models to support drug development decisions
Chrissie Fletcher, Using indirect treatment comparisons to support an HTA
Sorry, the comment form is closed at this time.